CareFirst taps Cognizant to support mHealth initiatives

Laura Pedulli | | Health Exec | Precision Medicine

CareFirst BlueCross BlueShield (CareFirst) selected Cognizant to support its mobile technology efforts for its 3.3 million members.

Under this partnership, Cognizant will establish a direct, secure connection for CareFirst members so they can utilize their smartphones and tablets to manage their health coverage, access information about physicians and claims, and obtain details about benefits. Cognizant will leverage its Mobility Testing Lab in Phoenix, for on-demand, cloud-based testing of mobile apps across multiple devices and carriers, according to an announcement.

"The ubiquity of smartphones and tablet devices, while rapidly changing customer expectations and operational needs, presents a powerful direct link for us to connect with our members and for our members to better manage their health care," Harry D. Fox, senior vice president for technical and operational support services at CareFirst, said in a statement.

This is not Cognizant’s only partnership with CareFirst. The company also provides business consulting, systems integration and application development solutions to support the insurer’s strategic and regulatory initiatives.

Laura Pedulli

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs

The American College of Cardiology has sent a letter to HHS Secretary Robert F. Kennedy Jr. that outlines some of the organization’s central priorities and concerns. 

Radiology Business
FDA announces recall of Medtronic interventional radiology devices after 17 injuries, 4 deaths

One product is being pulled from the market, and the other is receiving updated instructions for use.

AI in Healthcare
What federal regulators can learn from the states about AI oversight

If the Trump administration continues taking a laissez-faire stance toward AI—including AI used in healthcare—why not let the states go it alone on regulating the technology?